Neurology News and Research

Latest Neurology News and Research

Resection of brain regions with fast ripples may improve seizure outcome in pediatric epilepsy: Study

New research focusing on high-frequency oscillations, termed ripples and fast ripples, recorded by intracranial electroencephalography, may provide an important marker for the localization of the brain region responsible for seizure activity.

30 Jul 2011

Scientists examine relationship between REM sleep behaviour disorders, Parkinson's disease

Patients suffering REM sleep behaviour disorders dream nightmares in which they are attacked and pursued, with the particularity that they express them by screaming, crying, punching and kicking while sleeping.

30 Jul 2011

WSU professor receives NIH grant for non-alcoholic fatty liver disease research

Kezhong Zhang, Ph.D., assistant professor of molecular medicine and genetics and of immunology and microbiology in the School of Medicine at Wayne State University, was awarded $1.7 million by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to explore how molecular elements in the body regulate the development of non-alcoholic fatty liver disease.

29 Jul 2011

FDA issues Refusal to File letter for Eisai's perampanel NDA to treat partial-onset seizures

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Refusal to File letter in response to the company's New Drug Application (NDA) for perampanel (E2007), an investigational drug, for the treatment of partial-onset seizures associated with epilepsy which was submitted in May 2011.

29 Jul 2011

Drug to prevent brain ageing: Study

A new study shows that some chemicals given to rhesus macaques blocked a brain molecule that slows the firing of the brain's nerve cells, or neurons, as they age—prompting those nerve cells to act young again.

28 Jul 2011

Natus Medical second quarter revenue increases 10% to $58.1 million

Natus Medical Incorporated today announced financial results for the three and six months ended June 30, 2011.

28 Jul 2011

Cognitive behavioral therapy and self-help may improve unexplained symptoms of pain, fatigue

A new type of therapy may help people with symptoms such as pain, weakness, or dizziness that can't be explained by an underlying disease, according to a study published in the July 27, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Jul 2011

Inspiration presents OBI-1 pivotal study data on hemophilia at 23rd ISTH congress

Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. presented data from its clinical development program for OBI-1, an intravenous (IV) recombinant porcine factor VIII product (rpFVIII), intended for the treatment of bleeding in people with hemophilia A with inhibitors and in people with acquired hemophilia.

28 Jul 2011

Brain stimulation improves learning in people with schizophrenia

Very mild electrical brain stimulation could be used as a treatment for people with schizophrenia, say researchers.

28 Jul 2011

New enhanced MS ActiveSource for patients with multiple sclerosis

Biogen Idec today announced it has strengthened MS ActiveSource, its industry-leading suite of services for people with multiple sclerosis (MS), with the addition of new resources and support programs.

28 Jul 2011

No link between cell phone use and increased risk for brain cancer: European study

A new study that looked at cell phone users under the age of 20 found no link between cell phone use and an increased risk for brain cancer. Researchers from the Swiss Tropical and Public Health Institute in Basel, Switzerland, studied data collected in Norway, Denmark, Sweden and Switzerland.

27 Jul 2011

FDA accepts peginesatide NDA for anemia associated with CKD

Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for peginesatide (formerly known as Hematide™) for the treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis.

27 Jul 2011

Repligen first quarter total revenue increases 9% to $7,654,000

Repligen Corporation today reported results for the first quarter of fiscal year 2012, ended June 30, 2011.

27 Jul 2011

Mayo Clinic releases recommendations from the ice hockey concussion summit

Mayo Clinic has released recommendations from the Ice Hockey Summit on Concussion: A Call to Action. The summit attracted top scientists, trainers, coaches, officials and equipment manufacturers from across the United States, Canada and Europe to discuss concussion-related issues, including the science of concussions, impact on children, and prevention.

27 Jul 2011

Stenting prevents recurrence of aneurysms after minimally invasive 'coiling' procedure

The addition of a simple stent can help prevent potentially lethal blood vessel bulges in the brain from recurring after they are repaired in a minimally invasive "coiling" procedure, according to new research by Johns Hopkins physicians.

27 Jul 2011

Innovative MD leadership program for medical students

The first medical students enrolled in SELECT, an innovative program designed to educate the physician leaders of the future, will arrive on the USF Health campus this week.

27 Jul 2011

Special panel votes in favor of HDE approval for EXCOR Pediatric VAD

At the request of Dr. Bram Zuckerman, Director, Division of Cardiovascular Devices, Center for Devices and Radiologic Health of the United States Food and Drug Administration, a special panel was convened on Thursday July 21 in Gaithersburg, Maryland to review the results of the EXCOR® IDE clinical trial.

27 Jul 2011

Anavex presents data on neuroprotective evidence for lead compound for Alzheimer’s

Anavex Life Sciences Corp. is pleased to provide a summary of its second poster presentation at the Alzheimer’s Association International Conference (AAIC) held in Paris, entitled “Preclinical development of new tetrahydrofuran derivatives targeting the sigma-1 chaperone protein as neuroprotectants in Alzheimer’s disease.”

26 Jul 2011

Abbott announces research confirming presence of lutein in key regions of the infant brain

Preliminary new research demonstrates for the first time that lutein, an important phytonutrient (plant-based nutrient) that supports eye health, is the predominant carotenoid present in key areas of the infant brain, including areas that regulate overall brain function, cognition, vision, hearing and speech. This new research, supported by Abbott, was presented by Elizabeth Johnson, PhD, a scientist in the Carotenoids and Health Laboratory at Tufts University, at the 16th International Symposium on Carotenoids, in Krakow, Poland.

26 Jul 2011

Biogen Idec reports revenue of $1.2 billion for second quarter 2011

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its second quarter 2011 results.

26 Jul 2011

Neurology News and Research

Latest Neurology News and Research

Resection of brain regions with fast ripples may improve seizure outcome in pediatric epilepsy: Study

Scientists examine relationship between REM sleep behaviour disorders, Parkinson's disease

WSU professor receives NIH grant for non-alcoholic fatty liver disease research

FDA issues Refusal to File letter for Eisai's perampanel NDA to treat partial-onset seizures

Drug to prevent brain ageing: Study

Natus Medical second quarter revenue increases 10% to $58.1 million

Cognitive behavioral therapy and self-help may improve unexplained symptoms of pain, fatigue

Inspiration presents OBI-1 pivotal study data on hemophilia at 23rd ISTH congress

Brain stimulation improves learning in people with schizophrenia

New enhanced MS ActiveSource for patients with multiple sclerosis

No link between cell phone use and increased risk for brain cancer: European study

FDA accepts peginesatide NDA for anemia associated with CKD

Repligen first quarter total revenue increases 9% to $7,654,000

Mayo Clinic releases recommendations from the ice hockey concussion summit

Stenting prevents recurrence of aneurysms after minimally invasive 'coiling' procedure

Innovative MD leadership program for medical students

Special panel votes in favor of HDE approval for EXCOR Pediatric VAD

Anavex presents data on neuroprotective evidence for lead compound for Alzheimer’s

Abbott announces research confirming presence of lutein in key regions of the infant brain

Biogen Idec reports revenue of $1.2 billion for second quarter 2011

Aneuro: Advancing Neuroscience Research eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Neurology News and Research

Latest Neurology News and Research

Aneuro: Advancing Neuroscience Research eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in